Specialty | Gotoper.com

Allergy Newest Continuing Medical Education Live Events & Online Activities

Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Non-Hodgkin Lymphoma

Expires on
Dec 31, 2019

CME

1.5

Cancer Summaries and Commentaries™: Report from San Diego on Advancements in CAR T-Cell Therapy

Expires on
Dec 31, 2019

CME

0.75

Hematology Briefings™: The Evolving Management Landscape for Patients With Sickle Cell Disease: Opportunities, Challenges, and Emerging Agents for Therapy

Expires on
Dec 31, 2019

CME

1.0

Advances in™ Rare Diseases: Fatty Acid Oxidation Disorders – Improving Energy Production Through Alternative Sources

Expires on
Dec 31, 2019

CME

1.5

Advances In™ Therapies for Patients with Multiple Myeloma: More Options…More Decisions…Better Outcomes

Expires on
Dec 31, 2019

CME

0.5

Medical Crossfire®: Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): Optimizing the Diagnosis and Management Through Multidisciplinary, Patient-Centered Care

Expires on
Dec 31, 2019

CME

1.5

Medical Crossfire®: Cystic Fibrosis-Related Diabetes (CFRD): A Patient-Focused Approach to Early Recognition and Proper Treatment

Expires on
Dec 31, 2019

CME

1.5

Medical Crossfire®: Changing the Paradigm in Myelodysplastic Syndromes: How Do Patient Factors Impact Treatment Decisions?

Expires on
Dec 31, 2019

CME

2.0

Clinical Briefings^™: X-Linked Hypophosphatemia: Diagnosing and Addressing the Underlying Cause of the Disease

Expires on
Dec 31, 2019

CME

1.5

Real-World Evidence to Inform Treatment and Management of ER+ Metastatic Breast Cancer

Expires on
Dec 31, 2019

CME

1.0

6
ASH: MPN Tumor Board: Application of Novel Agents for the Treatment of Polycythemia Vera and Myelofibrosis
December 6, 2019
Orlando, FL
CME
3.0
ASH: Medical Crossfire^®: Case Studies in AYA and Adult Acute Lymphoblastic Leukemia – How the Experts Think and Treat
December 6, 2019
Orlando, FL
CME
3.0
ASH: The Evolving Treatment Landscape for Patients With GvHD: More Options, More Decisions, Better Outcomes!
December 6, 2019
Orlando, FL
CME
3.0
ASH: Primary HLH: Diagnosis, Management, and Treatment in the 21st Century
December 6, 2019
Orlando, FL
CME
2.0
ASH: Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL
December 6, 2019
Orlando, FL
CME
3.0

14
CARDIO-ENDO-RENAL COLLABORATIVE (CERC) Clinical Connections™
Expires on
Dec 14, 2019
CME
2.0
4th Annual International Congress on Immunotherapies in Cancer^®: Focus on Practice-Changing Application
December 14, 2019
New York, NY
CME
6.25
“D” Is for Diagnosis: Solving the Mystery of Lysosomal Storage Disorders
December 14, 2019
New York, NY
CME
3.0

21
Community Practice Connections™: 3rd Annual European Congress on Immunotherapies in Cancer™
Expires on
Dec 21, 2019
CME
1.5
Community Practice Connections™: Optimizing Outcomes for Patients With Acute Lymphoblastic Leukemia
Expires on
Dec 21, 2019
CME
1.5
Community Practice Connections™: Overcoming Clinical Inertia in Glioblastoma Multiforme: The Experts Weigh-In on Recent Data Sets and Next Steps to Move the Field Forward
Expires on
Dec 21, 2019
CME
1.5

30
Cancer Summaries and Commentaries™: Update from Munich: Advances in the Treatment of Lung Cancer, Genitourinary Malignancies, and Gynecologic Malignancies
Expires on
Dec 30, 2019
CME
2.25
Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of MPNs
Expires on
Dec 30, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of GvHD
Expires on
Dec 30, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Multiple Myeloma
Expires on
Dec 30, 2019
CME
2.0
Oncology Briefings™: Managing Pneumonitis in Patients with Stage III NSCLC
Expires on
Dec 30, 2019
CME
1.5
Oncology Briefings™: Updates in Waldenström Macroglobulinemia
Expires on
Dec 30, 2019
CME
1.0
Advances In™ the Management of Chronic Immune Thrombocytopenia
Expires on
Dec 30, 2019
CME
1.0
Advances in™ Hematology: Making Sense of Recent AML Approvals and Late-Stage Compounds
Expires on
Dec 30, 2019
CME
1.5

31
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Non-Hodgkin Lymphoma
Expires on
Dec 31, 2019
CME
1.5
Cancer Summaries and Commentaries™: Report from San Diego on Advancements in CAR T-Cell Therapy
Expires on
Dec 31, 2019
CME
0.75
Hematology Briefings™: The Evolving Management Landscape for Patients With Sickle Cell Disease: Opportunities, Challenges, and Emerging Agents for Therapy
Expires on
Dec 31, 2019
CME
1.0
Advances in™ Rare Diseases: Fatty Acid Oxidation Disorders – Improving Energy Production Through Alternative Sources
Expires on
Dec 31, 2019
CME
1.5
Advances In™ Therapies for Patients with Multiple Myeloma: More Options…More Decisions…Better Outcomes
Expires on
Dec 31, 2019
CME
0.5
Medical Crossfire®: Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): Optimizing the Diagnosis and Management Through Multidisciplinary, Patient-Centered Care
Expires on
Dec 31, 2019
CME
1.5
Medical Crossfire®: Cystic Fibrosis-Related Diabetes (CFRD): A Patient-Focused Approach to Early Recognition and Proper Treatment
Expires on
Dec 31, 2019
CME
1.5
Medical Crossfire®: Changing the Paradigm in Myelodysplastic Syndromes: How Do Patient Factors Impact Treatment Decisions?
Expires on
Dec 31, 2019
CME
2.0
Clinical Briefings^™: X-Linked Hypophosphatemia: Diagnosing and Addressing the Underlying Cause of the Disease
Expires on
Dec 31, 2019
CME
1.5
Real-World Evidence to Inform Treatment and Management of ER+ Metastatic Breast Cancer
Expires on
Dec 31, 2019
CME
1.0